Vol. 5 (2021): International Journal of Case Reports
Case Reports

Idiopathic retroperitoneal fibrosis and ankylosing spondylitis – A new case report with review of the literature

Soumaya Boussaid
la rabta hostital.

Keywords

  • Vestibular schwannoma, field cancerization, multiple primary tumours, pituitary adenoma

How to Cite

Soumaya Boussaid. (2021). Idiopathic retroperitoneal fibrosis and ankylosing spondylitis – A new case report with review of the literature. International Journal of Case Reports, 5, 196. Retrieved from https://escipub.org/index.php/IJCR/article/view/468

Abstract

Retroperitoneal fibrosis (RPF) is an uncommon disease (annual incidence estimated at 1/20,000–500,000) characterized by the development of dense fibrous tissue in the retroperitoneal compartment [1].
RPF can be idiopathic or secondary to drugs, infections, radiotherapy, malignant diseases, major abdominal surgery, trauma and retroperitoneal injuries [2,3]. RPF has also been reported in patients with systemic autoimmune diseases including rheumatic diseases [4-7]. Several cases of RPF in patients with ankylosing spondylitis have been described.
Herein, we report a new case of retroperitoneal fibrosis in a patient with ankylosing spondylitis.

References

  1. N. Pipitone, A. Vaglio, et C. Salvarani, « Retro-peritoneal fibrosis », Best Pract Res Clin Rheu-matol, vol. 26, no 4, p. 439?448, août 2012, doi: 10.1016/j.berh.2012.07.004.
  2. C. M. A. LeBlanc, R. D. Inman, P. Dent, C. Smith, P. Babyn, et R. M. Laxer, « Retroperitoneal fi-brosis: An extraarticular manifestation of anky-losing spondylitis », Arthritis Care & Research, vol. 47, no 2, p. 210?214, 2002, doi: 10.1002/art.10267.
  3. A. Bezza et al., « Idiopathic retroperitoneal fibro-sis and ankylosing spondylitis. A new case report », Joint Bone Spine, vol. 69, no 5, p. 502?505, oct. 2002, doi: 10.1016/s1297-319x(02)00438-4.
  4. « Mansell MA, Watts RW. Retroperitoneal fibrosis and scleroderma. Postgrad Med J 1980;56: 730-3. »
  5. « Lichon FS, Sequeira W, Pilloff A, Skosey JL. Retroperitoneal fibrosis associated with systemic lupus erythematosus: a case report and brief re-view. J Rheumatol 1984;11:373-4 ».
  6. « Gentric A, Herve JP, Cledes J. Idiopathic ret-roperitoneal fibrosis and Gougerot-Sjogren syn-drome. Presse Med 1987;16:1702. »
  7. « Tsai TC, Chang PY, Chen BF, Huang Fy, Shin SL. Retroperitoneal fibrosis and juvenile rheu-matoid arthritis. Pediatr Nephrol 1996;10: 208-9. »
  8. « Symmons RE, Dahlin DC, Engel S. Idiopathic retroperitoneal fibrosis. Obstet Gynecol 1961;18: 591-6 ».
  9. « Reidbord HE, Hawk WA. Idiopathic retroperi-toneal fibrosis and necrotising vasculitis. Cleve Clin Q 1965;32:19-27. »
  10. « Hissong SL, Freimanis AK. Retroperitoneal fi-brosis: extraperitoneal lesions (report of 3 unusual areas of involvement). Am J Roentgenol 1969;107:776-84. »
  11. « De Meulder A, Dutrieux JL. Rapport d’un cas de fibrose retroperitoneal associée à une spon-dylarthrite ankylosante. Louvain Med 1977;96: 387-94. »
  12. « Vital-Durand D, Rouhier D, Brette R.Associati-a. on fibrose retroperitoneale- spon-dylarthrite ankylosante: une nouvelle observation. Ann Med Interne (Paris) 1981;132:200-1. »
  13. « Littlejohn GO, Keystone EC. The association of retroperitoneal fibrosis with systemic vasculitis and HLA–B27: a case report and review of the literature. J Rheumatol 1981;8:6659. »
  14. « Thorel JB, Toulet R, Lenormand JP, Schmitt B. Fibrose retroperitoneale idiopathique chez un sujet porteur d’un antigene HLA-B27. Rev Rheum (Engl Ed) 1982;49:891-5. »
  15. « Goldbach P, Mohsenifar Z, Salick AI. Familial mediastinal fibrosis associated with seronegative spondylarthropathy. Arthritis Rheum 1983; 26:221-5. »
  16. « Solomon SD, Maurer KH. The association of retroperitoneal fibrosis and ankylosing spondyli-tis. J Rheumatol 1985;12:818. »
  17. « Wicks IA, Robertson MR, Murnahan GF, Ber-touch JV. Idiopathic retroperitoneal fibrosis pre-senting with back pain. J Rheumatol 1988;15: 1572-4. »
  18. « Reilly PA, Moran CJ. Retroperitoneal fibrosis in radiotherapy treated ankylosing spondylitis. Br J Rheumatol 1989;28:273-4. »
  19. « De la Iglesia Martinez F, Grana Gil J, Gomez Veiga F, Rodiguez Garcia J, Gomez Rodriguez N, Atanes Sandoval A. The association of idiopathic retroperitoneal fibrosis and ankylosing spondyli-tis. J Rheumatol 1992;19:1147-9. »
  20. « Azias I, Roblot P, Barrier J, Debiasis F, Becq-Giraudon B, Bontoux D. Fibrose retroperi-toneale idiopathique et spondylarthrite anky-losante. Rev Rheum (Engl Ed) 1993;321-4. »
  21. « Astudillo L, Alric L, Jamard B, Laroche M. Fi-brose retroperitoneale chez un patient HLA-B27 positif. Rev Med Interne 1999;20:1149-50. »
  22. M. Takahashi, A. Ishikawa, et H. Kondo, « [A case of seronegative spondylarthropathy with iritis and retroperitoneal fibrosis] », Ryumachi, vol. 39, no 1, p. 17?21, févr. 1999.
  23. « Wendling D, Toussirot E, Michel F. Spon-dylarthropathy and retroperitoneal fibrosis: a case report. Joint Bone Spine 2002;69:334-7. »
  24. A. Afeltra et al., « Retroperitoneal fibrosis and ankylosing spondylitis: which links? », Semin. Arthritis Rheum., vol. 35, no 1, p. 43?48, août 2005, doi: 10.1016/j.semarthrit.2005.03.003.
  25. S. Manganelli, C. Giannitti, M. Galeazzi, et M. Rossi, « Retroperitoneal fibrosis following a long-standing etanercept treatment in a spondy-loarthritis patient », Joint Bone Spine, vol. 85, no 3, p. 389?390, 2018, doi:10.1016/j.jbspin.2017.05. 024.
  26. E. Masson, « La fibrose rétropéritonéale », EM-Consulte. a. https://www.em-consulte.com/article/1285658/la-fibrose-retroperitoneale(consulté le mai 28, 2020).
  27. « Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet 2006; 367:241–51. »
  28. « Jois RN, Gaffney K, Marshall T, Scott DGI. Ch- ronic periaortitis. Rheumatol 2004;43:1441–6. »
  29. « Vaglio A, Corradi D, Manenti L, Ferretti S, Garini G, Buzio C. Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med 2003;114:454–62. »
  30. « Vaglio A, Buzio C. Chronic periaortitis: a spec-trum of diseases. Curr Opin Rheumatol 2005; 17:34–40. »
  31. « Kottra JJ, Dunnick NR. Retroperitoneal fibrosis. Radiol Clin North Am 1996;43:1259–75. »
  32. « Tang CS, Sivarasan N, Griffin N. Abdominal manifestations of IgG4-related disease: a pictorial review. Insights Imaging 2018;9:437–48. »
  33. « Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related auto-immune disease. J Gastroenterol 2003;38:982–4. »
  34. E. Masson, « Fibrose rétropéritonéale?: une maladie vasculaire ou immunitaire responsable de lombalgie », EM-Consulte. https://www.em-consulte.com/article/66899/fibrose-retroperitoneale-une-maladie-vasculaire-ou (consulté le mai 28, 2020).
  35. E. Masson, « La fibrose rétropéritonéale », EM-Consulte. a. https://www.em-consulte.com/article/1280652/la-fibrose-retroperitoneale(consulté le août 03, 2020).
  36. T. Tanaka et N. Masumori, « Current approach to diagnosis and management of retroperitoneal fi-brosis », Int. J. Urol., vol. 27, no 5, p. 387?394, mai 2020, doi: 10.1111/iju.14218.
  37. « Marcolongo R, Tavolini IM, Laveder F, Busa M, Noventa F, Bassi P, et al. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. Am J Med 2004;116:194–7. »
  38. « Warnatz K, Keskin AG, Uhl M, Scholz C, Kat-zenwadel A, Vaith P, et al. Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis 2005; 64:828–33. »
  39. « Baker LR, Mallinson WJ, Gregory MC, Menzies EA, Cattell WR, Whitfield HN, et al. Idiopath-a. ic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol 1987;60:497–503. »